FeesSafety
Pluang+

Privia Health Group rated BUY with strong growth and a 48% valuation discount

Analyst Insights
22 Oct 2026
Seeking Alpha
View Source
Bullish
Privia Health Group rated BUY with strong growth and a 48% valuation discount

Privia Health Group (PRVA) is rated a BUY due to its strong operating leverage and growth in value-based care, which supports potential earnings upside. The stock trades at a 48% discount to its five-year average forward EV/EBITDA, with expected forward EBITDA growth of 24%, outperforming its peers. In Q2 2026, Privia reported 15% growth in care margins and 29% growth in adjusted EBITDA, alongside expanding provider and patient networks, highlighting operational efficiency. The company also maintains a debt-free balance sheet with $412 million in cash and reinvests its strong free cash flow, positioning it well for future growth.

Privia Health Group's strong operating leverage and growth prospects come as 67 of 150 priced US health-sector stocks on Pluang rose while 79 fell. For readers following the health sector, here is Pluang's market snapshot as of Oct 22, 2026 13:11 WIB: Twist Bioscience Corp (TWST) traded at USD 142.80 with a 1-day change of -4.24% and 93% buy order activity, Danaher Corporation (DHR) at USD 233.00 up 4.01% with 88% buy orders, and Tilray Brands Inc (TLRY) at USD 2.92 down 3.63% with 100% buy orders. Typical hold times ranged from 27 to 69 days.

More News

Lockheed Martin beats Q3 2026 earnings estimates with record backlog of $292B

Lockheed Martin beats Q3 2026 earnings estimates with record backlog of $292B

Lockheed Martin reported strong Q3 2026 results, beating Wall Street estimates with earnings of $7.97 per share and sales of $20.7 billion, up 11% year-over-year. Net earnings rose 14% to $1.8 billion, supported by a record backlog of $292 billion, i...

Company Fundamentals
Bullish
45 minutes ago
IBM's Q3 beats expectations, software growth drives price target hike to $280

IBM's Q3 beats expectations, software growth drives price target hike to $280

IBM reported strong Q3 results with revenue of $17.1 billion and adjusted earnings of $2.95 per share, surpassing analyst estimates. Software revenue grew 9%, led by Red Hat and OpenShift, while AI-related consulting work also contributed significant...

Company Fundamentals
Bullish
1 hour ago
CenterPoint Energy gets 'Buy' rating ahead of Q3 earnings with expected $2.16B revenue and $0.50 EPS.

CenterPoint Energy gets 'Buy' rating ahead of Q3 earnings with expected $2.16B revenue and $0.50 EPS.

Cowen & Co. initiated a 'Buy' rating on CenterPoint Energy before its Q3 earnings report due October 27, 2026. Analysts expect $2.16 billion in revenue, an 8.4% increase year-over-year, and earnings of $0.50 per share, steady from last year. The comp...

Analyst Insights
Bullish
1 hour ago
Drofa Comms launches Women Leading the Way 2026 to promote equal recognition for women experts in finance.

Drofa Comms launches Women Leading the Way 2026 to promote equal recognition for women experts in finance.

Drofa Comms has released the Women Leading the Way Digital Magazine 2026, aiming to highlight women experts in finance on equal terms with men. The digital magazine features insights from 25 industry professionals and covers topics like AI in wealth ...

Others
Neutral
1 hour ago
Tesla cuts capital spending guidance, shares drop after Q3 earnings despite strong cash flow

Tesla cuts capital spending guidance, shares drop after Q3 earnings despite strong cash flow

Tesla reported third-quarter earnings with free cash flow exceeding expectations, but shares fell after hours despite an initial gain. The company lowered its full-year capital expenditure forecast to about $20 billion from over $25 billion, signalin...

Analyst Insights
Neutral
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App